Vaccinex's lead drug misses the mark in Huntington phase 2; focus shifts to Alzheimer's - FierceBiotech

Submitted by Anonymous (not verified) on Tue, 09/22/2020 - 11:30

Vaccinex's lead drug misses the mark in Huntington phase 2; focus shifts to Alzheimer's  FierceBiotech